Intestine and Lower Gastrointestinal Tract ·
Further validation through large-scale trials is needed to confirm their efficacy.
Review by Chen E, Chen L, Zhang W and Zhou W in Int J Colorectal Dis
© 2025. The Author(s).
Summaries are written to help you decide what to read. They do not replace the full paper.
Free · 5 minutes a day
Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.
More in Intestine and Lower Gastrointestinal Tract
A Japanese randomized trial found that a 14-day schedule of trifluridine-tipiracil plus bevacizumab keeps patients with metastatic colorectal cancer alive as long as the standard 28-day schedule, with far less toxicity.
Five years after surgery for low rectal cancer, patients operated on robotically did as well as those operated on laparoscopically, according to a randomized trial from three Korean centres.
Patients smoking at diagnosis were less likely to have a favorable response to treatment before rectal cancer surgery; former smokers were not.
